A significant proportion of patients receiving digitalis in primary care lack a clearly defined underlying heart disease or documented treatment effectiveness, highlighting the need for careful evaluation of indications.
Answers are grounded in this paper and cite their sources.
Digitalis often lacks documented indications or efficacy in primary care; supports audits of prescribing but should not yet change practice.
A retrospective study of 323 patients on digitalis therapy was performed in the primary care area of Skellefteå health district with the highest prescription of cardiac glycosides. The study comprised 90% of all patients on digitalis. Indications for treatment and the underlying heart disease were especially scrutinized. In one-third of all patients no underlying heart disease was defined and in about half of them the effectiveness of treatment was poorly documented. The study underlines the importance of defining the indication for treatment combined with a subsequent careful evaluation of the therapy in order to optimize treatment with cardiac glycosides.
No takes yet. Share an insight, caveat, or question.
Boman et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: